Pages that link to "Q43157369"
Jump to navigation
Jump to search
The following pages link to Ketogenic diet slows down mitochondrial myopathy progression in mice (Q43157369):
Displaying 50 items.
- Ketogenic diet in neuromuscular and neurodegenerative diseases (Q21284703) (← links)
- AAV-mediated liver-specific MPV17 expression restores mtDNA levels and prevents diet-induced liver failure (Q24622009) (← links)
- Harnessing the power of metabolism for seizure prevention: focus on dietary treatments (Q26991869) (← links)
- Emerging concepts in the therapy of mitochondrial disease (Q26995777) (← links)
- Mitochondrial disorders: challenges in diagnosis & treatment (Q27000484) (← links)
- Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle (Q27009396) (← links)
- Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry (Q28395402) (← links)
- Partial complex I deficiency due to the CNS conditional ablation of Ndufa5 results in a mild chronic encephalopathy but no increase in oxidative damage (Q28587077) (← links)
- Mitochondria: in sickness and in health (Q29614825) (← links)
- 3-Hydroxybutyrate methyl ester as a potential drug against Alzheimer's disease via mitochondria protection mechanism (Q30654929) (← links)
- Therapies in inborn errors of oxidative metabolism. (Q34055267) (← links)
- Mouse studies to shape clinical trials for mitochondrial diseases: high fat diet in Harlequin mice (Q34103418) (← links)
- Detailed mitochondrial phenotyping by high resolution metabolomics (Q34193645) (← links)
- Therapeutic prospects for mitochondrial disease (Q34205124) (← links)
- Ketone bodies as signaling metabolites. (Q34252732) (← links)
- Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3 (Q34372265) (← links)
- Potential therapeutic use of the ketogenic diet in autism spectrum disorders (Q34431317) (← links)
- Ketogenic diets: from cancer to mitochondrial diseases and beyond. (Q34509699) (← links)
- A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease (Q35023971) (← links)
- Effect of one month duration ketogenic and non-ketogenic high fat diets on mouse brain bioenergetic infrastructure. (Q35061793) (← links)
- MTO1 mediates tissue specificity of OXPHOS defects via tRNA modification and translation optimization, which can be bypassed by dietary intervention (Q35234097) (← links)
- Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function (Q35660977) (← links)
- Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies (Q35893619) (← links)
- Mitochondrial Dysfunction Plus High-Sugar Diet Provokes a Metabolic Crisis That Inhibits Growth (Q35904888) (← links)
- Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS. (Q35919630) (← links)
- The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics (Q36846068) (← links)
- The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome (Q36853449) (← links)
- Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress (Q37369860) (← links)
- Effects of ketosis in mitochondrial myopathy: potential benefits of a mitotoxic diet (Q37386977) (← links)
- Modified Atkins diet induces subacute selective ragged-red-fiber lysis in mitochondrial myopathy patients. (Q37386981) (← links)
- Tissue Specific Impacts of a Ketogenic Diet on Mitochondrial Dynamics in the BTBRT tf/j Mouse. (Q37532934) (← links)
- Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches (Q37653680) (← links)
- Development of pharmacological strategies for mitochondrial disorders (Q37686237) (← links)
- The human mitochondrial replication fork in health and disease (Q37736777) (← links)
- Mitochondrial myopathies: developments in treatment (Q37774832) (← links)
- Neurodevelopmental manifestations of mitochondrial disease. (Q37784963) (← links)
- Emerging therapeutic approaches to mitochondrial diseases (Q37785521) (← links)
- Biomarkers for mitochondrial respiratory chain disorders (Q37799755) (← links)
- Mitochondrial response to controlled nutrition in health and disease (Q37835867) (← links)
- Therapy for mitochondrial disorders: Little proof, high research activity, some promise (Q37890117) (← links)
- Mechanisms of mitochondrial diseases (Q37909459) (← links)
- Neuroprotection in metabolism-based therapy (Q37923014) (← links)
- Comprehensive two-dimensional gas chromatography in metabolomics (Q37976294) (← links)
- Mitochondrial disease and epilepsy (Q37979255) (← links)
- Drugs and mitochondrial diseases: 40 queries and answers. (Q37980195) (← links)
- Ketogenic diets: new advances for metabolism-based therapies (Q37982950) (← links)
- Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: an important cause of stroke in young people. (Q37983523) (← links)
- Mitochondrial respiratory chain disorders in childhood: insights into diagnosis and management in the new era of genomic medicine. (Q38174984) (← links)
- Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases (Q38194264) (← links)
- Epilepsy, energy deficiency and new therapeutic approaches including diet. (Q38219880) (← links)